AlbionVC supports visionary founders and technologies with long-term capital and scale-up know-how, serving as the technology investment arm of Albion Capital Group.
The round was co-led by Plural, Playground Global, and Novo Holdings.
"We’re actively creating quantum advantage at Phasecraft. Our algorithms are delivering meaningful results now, whether it’s simulating the physics of complex materials or optimizing the structure of a large energy network, whilst our partnerships with the world’s top quantum hardware providers increase the impact our algorithms will have for commercial applications. We’re delighted to have the backing of our visionary investors such as Plural, Playground Global, and Novo Holdings, to support us on the mission to bring quantum advantage to the world faster."
Notion Capital led the Series B round to support the company expansion across North America, APAC, and Europe.
"Our world runs on nature-based commodities, yet information on the physical source of these assets remains largely invisible to the systems that depend on them. Data informs the flow of capital, and at Treefera we equip enterprises with the clarity to strengthen supply chain resilience, secure future revenue, and scale the upside of regenerative practices. With defensible real-time insights on commodities, ingredients and carbon from the first-mile, businesses can not only have clearer sightlines into sourcing but mitigate risk and ensure compliance. This backing led by Notion Capital enables us to accelerate our mission globally for the benefit of business and planet."
The funding round was led by AlbionVC with participation from a16z Crypto and CMCC Global.
"Stablecoins play a critical role in the crypto ecosystem, bridging that gap between digital assets and traditional finance. As the crypto ecosystem continues to mature, our technology empowers fintechs and exchanges to offer stablecoin yield products that are seamlessly integrated, safe and fast, matching high demand levels. This funding allows us to continue on our growth trajectory, building products for some of the biggest and most important leaders in the space. The caliber and experience of our partners is testament to the solutions we’ve built and the fantastic team we’ve got here at OpenTrade. Onwards and upwards."
Notion Capital led the follow-on investment round, backed by existing supporters including M12 and Nationwide.
"We are incredibly excited to be part of this funding round in Hazy. We believe that synthetic data will open a world of opportunities for large enterprises to use their data, extract insights and train their models among others, without compromising their customers’ information."
Atomico led the Series A investment to support geographic expansion and team growth.
"Despite being critical infrastructure for our society, childcare has been overlooked for far too long. We’ve already seen how profoundly our services can improve the well-being of families, as well as older adults and children who have a chance to connect with another generation while working. We’re excited for Atomico to help us scale our vision of building a completely new way of doing childcare so even more families can benefit."
The investment round was led by AlbionVC, with participation from Downing Ventures and Unilever Ventures.
"There is an opportunity for brands to transform their customer service by leveraging the power of the crowd. Creating a customer community which engages and rewards customers for helping other customers is the future – it is better, faster and cheaper. However, executing this at scale needs a rare combination of tech savvy and deep domain expertise – which Team Limitless have in spades from the previous business they built. We are proud to support Roger and Megan achieve their exciting vision."
Apposite Capital has led a £6m Series A round in Mirada Medical to accelerate the development of artificial intelligence for cancer care.
"The use of AI in healthcare is growing quickly. We are excited to be able to accelerate our development of AI-based cancer treatment planning. Apposite’s focus on healthcare and their solid pedigree in the Radiation Therapy sector provides Mirada with invaluable resource over and above the significant financial investment they have made. Mirada’s products will make a transformative impact on the day-to-day provision of cancer care, through the deployment of advanced AI-powered technology."